What does APOTHEEK PUTTEMANS-VERNAILLEN do?

APOTHEEK PUTTEMANS-VERNAILLEN is a pharmacy in Putte. Public Limited, started on 30 September 1985, 1 establishment.

What is the address of APOTHEEK PUTTEMANS-VERNAILLEN?

The registered office of APOTHEEK PUTTEMANS-VERNAILLEN is located at Lierbaan 37, 2580 Putte.

Is APOTHEEK PUTTEMANS-VERNAILLEN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK PUTTEMANS-VERNAILLEN is active, legal situation “Normale toestand”, started on 30 September 1985.

Is APOTHEEK PUTTEMANS-VERNAILLEN registered on Peppol?

Yes, APOTHEEK PUTTEMANS-VERNAILLEN is registered on the Peppol network with ID 0208:0427909758.

What is the enterprise number of APOTHEEK PUTTEMANS-VERNAILLEN?

The enterprise number of APOTHEEK PUTTEMANS-VERNAILLEN is BE0427909758.

When was APOTHEEK PUTTEMANS-VERNAILLEN founded?

APOTHEEK PUTTEMANS-VERNAILLEN was founded on 30 September 1985.

Who are the directors of APOTHEEK PUTTEMANS-VERNAILLEN?

According to the 2025 annual accounts, the directors of APOTHEEK PUTTEMANS-VERNAILLEN are: Panacea Pharma BV.

Is APOTHEEK PUTTEMANS-VERNAILLEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 September 1985; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK PUTTEMANS-VERNAILLEN make in 2025?

APOTHEEK PUTTEMANS-VERNAILLEN posted a profit after taxes of € 147,974 in financial year 2025.

What is the revenue of APOTHEEK PUTTEMANS-VERNAILLEN?

As a small company, APOTHEEK PUTTEMANS-VERNAILLEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 413,332.

How much does an employee at APOTHEEK PUTTEMANS-VERNAILLEN earn?

The average wage cost per full-time employee at APOTHEEK PUTTEMANS-VERNAILLEN was € 69,700 in 2025: staff costs of € 139,365 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK PUTTEMANS-VERNAILLEN have?

According to the 2025 annual accounts, APOTHEEK PUTTEMANS-VERNAILLEN has 2 full-time equivalents (FTE).

Does APOTHEEK PUTTEMANS-VERNAILLEN have a website?

Yes, APOTHEEK PUTTEMANS-VERNAILLEN has a website at apotheek-puttemans.be.

APOTHEEK PUTTEMANS-VERNAILLEN (Public Limited) - Putte

Dossier APOTHEEK PUTTEMANS-VERNAILLEN, printed on 30 October 2026 from databakkes.be/en/0427909758/apotheek-puttemans-vernaillen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK PUTTEMANS-VERNAILLEN from Putte, company number BE0427909758, closed financial year 2025 with a result of € 147,974 after tax. For that financial year APOTHEEK PUTTEMANS-VERNAILLEN recorded a gross margin of € 413,332 and equity of € 897,452. Compared with financial year 2024, the result moved from € 142,079 to € 147,974. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.

What it is worth Growing

€ 897,452

▲ 6% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 147,974

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 142,961

▼ 26% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

68 % of the profit went to the shareholders, mostly to Panacea Pharma (95 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 139,365

▲ 7% vs 2024

€ 69,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 77,155

▲ € 74,999 vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 128,738

▼ 21% vs 2024

€ 34,407 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 114,094

▲ 46% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 16,057

▼ 26% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 335,109 Gross margin 2022: € 335,109 First fiscal year in the series	€ 337,381 Gross margin 2023: € 337,381 ▲ 1% vs 2022 (€ 335,109) Favourable step	€ 381,296 Gross margin 2024: € 381,296 ▲ 13% vs 2023 (€ 337,381) Favourable step	€ 413,332 Gross margin 2025: € 413,332 ▲ 8% vs 2024 (€ 381,296) Favourable step	▲ 8%
Profit after taxes	€ 108,691 Profit after taxes 2022: € 108,691 First fiscal year in the series	€ 108,101 Profit after taxes 2023: € 108,101 ▼ 1% vs 2022 (€ 108,691) Unfavourable step	€ 142,079 Profit after taxes 2024: € 142,079 ▲ 31% vs 2023 (€ 108,101) Favourable step	€ 147,974 Profit after taxes 2025: € 147,974 ▲ 4% vs 2024 (€ 142,079) Favourable step	▲ 4%
Equity	€ 699,298 Equity 2022: € 699,298 First fiscal year in the series	€ 707,399 Equity 2023: € 707,399 ▲ 1% vs 2022 (€ 699,298) Favourable step	€ 849,478 Equity 2024: € 849,478 ▲ 20% vs 2023 (€ 707,399) Favourable step	€ 897,452 Equity 2025: € 897,452 ▲ 6% vs 2024 (€ 849,478) Favourable step	▲ 6%
Total debts	€ 377,571 Total debts 2022: € 377,571 First fiscal year in the series	€ 354,441 Total debts 2023: € 354,441 ▼ 6% vs 2022 (€ 377,571) Favourable step	€ 300,308 Total debts 2024: € 300,308 ▼ 15% vs 2023 (€ 354,441) Favourable step	€ 296,963 Total debts 2025: € 296,963 ▼ 1% vs 2024 (€ 300,308) Favourable step	▼ 1%
Cash	€ 140,137 Cash 2022: € 140,137 First fiscal year in the series	€ 131,154 Cash 2023: € 131,154 ▼ 6% vs 2022 (€ 140,137) Unfavourable step	€ 194,051 Cash 2024: € 194,051 ▲ 48% vs 2023 (€ 131,154) Favourable step	€ 142,961 Cash 2025: € 142,961 ▼ 26% vs 2024 (€ 194,051) Unfavourable step	▼ 26%
Land & buildings	€ 342,917 Land & buildings 2022: € 342,917 First fiscal year in the series	€ 329,508 Land & buildings 2023: € 329,508 ▼ 4% vs 2022 (€ 342,917) Unchanged	€ 316,098 Land & buildings 2024: € 316,098 ▼ 4% vs 2023 (€ 329,508) Unchanged	€ 302,689 Land & buildings 2025: € 302,689 ▼ 4% vs 2024 (€ 316,098) Unchanged	▼ 4%
Retained profit	€ 637,298 Retained profit 2022: € 637,298 First fiscal year in the series	€ 645,399 Retained profit 2023: € 645,399 ▲ 1% vs 2022 (€ 637,298) Favourable step	€ 787,478 Retained profit 2024: € 787,478 ▲ 22% vs 2023 (€ 645,399) Favourable step	€ 835,452 Retained profit 2025: € 835,452 ▲ 6% vs 2024 (€ 787,478) Favourable step	▲ 6%
Dividend	€ 106,000 Dividend 2022: € 106,000 First fiscal year in the series	€ 100,000 Dividend 2023: € 100,000 ▼ 6% vs 2022 (€ 106,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 100,000) Unchanged	€ 100,000 Dividend 2025: € 100,000 Unchanged (€ 0) Unchanged
Bank debt	€ 228,899 Bank debt 2022: € 228,899 First fiscal year in the series	€ 196,015 Bank debt 2023: € 196,015 ▼ 14% vs 2022 (€ 228,899) Favourable step	€ 162,630 Bank debt 2024: € 162,630 ▼ 17% vs 2023 (€ 196,015) Favourable step	€ 128,738 Bank debt 2025: € 128,738 ▼ 21% vs 2024 (€ 162,630) Favourable step	▼ 21%
Balance sheet total	€ 1,076,868 Balance sheet total 2022: € 1,076,868 First fiscal year in the series	€ 1,061,840 Balance sheet total 2023: € 1,061,840 ▼ 1% vs 2022 (€ 1,076,868) Unchanged	€ 1,149,785 Balance sheet total 2024: € 1,149,785 ▲ 8% vs 2023 (€ 1,061,840) Unchanged	€ 1,194,415 Balance sheet total 2025: € 1,194,415 ▲ 4% vs 2024 (€ 1,149,785) Unchanged	▲ 4%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	2 Employees (FTE) 2023: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2024: 2 Unchanged (2) Unchanged	2 Employees (FTE) 2025: 2 Unchanged (2) Unchanged

Key figures of APOTHEEK PUTTEMANS-VERNAILLEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK PUTTEMANS-VERNAILLEN?

What happened at APOTHEEK PUTTEMANS-VERNAILLEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 16, 2026 New annual accounts for financial year 2025: profit of € 147,974 (▲ 4% vs 2024). Source: NBB ↗
2023 Panacea Pharma BV became a director. NBB
Oct 1, 1985 New establishment in Putte. KBO
Sep 30, 1985 Start of the company according to the CBE. KBO

In short

From € 108,691 profit in 2022 to € 147,974 profit in 2025.

Paid € 174,005 in corporate taxes since 2022.

Best year ever: 2025, with € 147,974 profit.

On average € 206,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

Panacea Pharma 94.9%

The stake of Panacea Pharma comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK PUTTEMANS-VERNAILLEN

Behind APOTHEEK PUTTEMANS-VERNAILLEN is Panacea Pharma BV. The shares are held by Panacea Pharma (94.9%).

Directors

According to the 2025 annual accounts

Panacea Pharma BV

Managing director · represented by Puttemans Stefan

since 2023

Shareholders

Panacea Pharma

94.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Lierbaan 37

2580 Putte

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Panacea Pharma same network

€ 111,948 gross margin · 2025

Vereniging van mede-eigenaars Residentie De Farmacie

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheek-puttemans.be

About

Technologies

Alpine.jsApacheBunny CDNFont AwesomeGoogle FontsSwiperreCAPTCHA

Hosting & Email

Hosting

AMAZON-02 - Amazon.com, Inc., US

DNS

AWS Route 53

Website info

HTTPS Ja

Languages NL

Features

Webshop Client portal Contact page

Security

✓ HTTPS

✗ SPF

✓ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number

0427.909.758

VAT number

BE 0427.909.758

Registered office

Lierbaan 37, 2580 Putte

Names & denominations

APOTHEEK PUTTEMANS-VERNAILLEN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

30 September 1985

Peppol

Active · Active since 17 Dec 2025

Contact

apotheek-puttemans.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK PUTTEMANS-VERNAILLEN

Financials

What happened to APOTHEEK PUTTEMANS-VERNAILLEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions